Sal Gorus’ Post

View profile for Sal Gorus, graphic

AI Powered: Regulatory Intelligence - R&D Quality - Competitive Intelligence

💡 Why This Matters: - Enhanced Protection: With broader serotype coverage, Capvaxive promises improved defense against pneumococcal disease for adults, particularly those over 50. - Aging Population: As our global population ages, innovations like Capvaxive are crucial in reducing disease burden and healthcare costs. - Public Health Impact: Improved vaccines contribute to overall public health resilience, preventing serious illnesses and hospitalizations among vulnerable groups.

To view or add a comment, sign in

Explore topics